Clinical Trial Update: Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder. [Phase 2]

View source ↗

Summary

This Phase 2 trial assessed the efficacy and safety of botulinum toxin A for refractory overactive bladder and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Overactive Bladder | Phase 2 | Status: COMPLETED